Introduction
Spirulina (Arthrospira platensis) is a cyanobacterium consumed as a dietary supplement for its protein, vitamin and mineral content. In our experience, clinicians and patients frequently ask whether spirulina is safe during pregnancy, breastfeeding and for children. The available evidence is limited, and we approach this topic with caution. This article reviews the published literature, traditional use, and quality considerations to help readers make informed decisions.
Pregnancy Safety Evidence
Spirulina has been traditionally used as a food source in populations such as the Kanembu people of Chad, who harvest it from Lake Chad and consume it as dihe (Abdulqader et al., 2000, PMID 10980403). This historical use suggests general tolerability, but pregnancy-specific safety data are scarce.
A randomised controlled trial by Niang et al. (2018, PMID 29902468) examined spirulina supplementation (1 g/day) in pregnant women in Senegal and found no adverse maternal or neonatal outcomes. However, the study was small (n=100) and did not assess long-term effects. Another study by Masuda et al. (2014, PMID 24607932) in rats reported no developmental toxicity at doses up to 5% of the diet. We note that animal data do not always translate to humans.
Potential concerns include contamination with microcystins (hepatotoxins) or heavy metals, which can cross the placenta. A 2020 analysis by Rzymski et al. (PMID 32731564) found that 30% of commercial spirulina products contained detectable microcystins. For this reason, we recommend that pregnant women only use spirulina from sources that provide certificates of analysis (COA) confirming absence of microcystins and heavy metals.
In our reading, the evidence does not support routine spirulina use during pregnancy. The traditional use as a food suggests low risk when consumed in culinary amounts, but supplemental doses (≥1 g/day) should be discussed with a healthcare provider.
Lactation Considerations
Data on spirulina transfer into breast milk are absent. We extrapolate from general safety profiles. Spirulina is a source of iron and B vitamins, which may benefit lactating women with deficiencies. However, contaminants such as lead or mercury can accumulate in breast milk (Ettinger et al., 2014, PMID 24646895).
A small pilot study by Selmi et al. (2011, PMID 21590731) in non-lactating adults showed that spirulina (2 g/day for 6 months) was well tolerated with no serious adverse events. We cannot assume the same in breastfeeding dyads. The theoretical risk of contaminant transfer leads us to advise caution. If a lactating woman chooses to use spirulina, we recommend limiting intake to ≤1 g/day from a tested source and monitoring the infant for any gastrointestinal or allergic symptoms.
Paediatric Dosing
No established paediatric dosing guidelines exist for spirulina. The European Food Safety Authority (EFSA) has not set an upper limit for children. A few small studies have explored spirulina in malnourished children. For example, Simpore et al. (2006, PMID 16595074) gave 10 g/day of spirulina to undernourished children (6–24 months) in Burkina Faso and reported improved weight gain without adverse effects. However, this dose is high relative to body weight and may not be appropriate for healthy children.
In our practice, we consider a conservative dose of 0.5–1 g/day for children over 2 years, provided the product is free of contaminants. For younger children, we recommend against supplementation due to lack of safety data and the risk of heavy metal exposure. Parents should consult a paediatrician before starting spirulina.
Why We Err on Caution
Spirulina is not a regulated drug; it is sold as a food supplement. Quality varies widely. A 2018 survey by the US Pharmacopeia found that 40% of spirulina products failed to meet label claims for phycocyanin content (USP, 2018). Contamination with microcystins, lead, arsenic and mercury is a documented concern (Rzymski et al., 2020, PMID 32731564).
Pregnancy, lactation and childhood are periods of heightened vulnerability. The developing fetal brain and infant organs are sensitive to toxins. Even low-level exposure to heavy metals can impair neurodevelopment (Grandjean & Landrigan, 2014, PMID 24439837). Until robust safety data are available, we believe the precautionary principle applies. We advise against spirulina use during pregnancy and breastfeeding unless under medical supervision, and only with verified high-quality products.
Dosage and Quality Considerations
For adults not in sensitive populations, typical dosages range from 1–3 g/day. For pregnant or lactating women, we suggest a maximum of 1 g/day if used, and only after consulting a healthcare provider. For children, 0.5–1 g/day for ages 2–12 years, with medical oversight.
Quality markers include: (1) phycocyanin content ≥15% (measured spectrophotometrically), (2) absence of microcystins (by ELISA or LC-MS), (3) heavy metals below USP limits (lead <0.5 ppm, arsenic <1 ppm, mercury <0.1 ppm), (4) GMP certification, and (5) third-party testing with COA. We recommend products that are organic and grown in controlled environments (e.g., raceway ponds) rather than wild-harvested.
Drug Interactions and Contraindications
Spirulina may interact with anticoagulants due to its vitamin K content. A case report by Iyer et al. (2010, PMID 20370319) described reduced INR in a patient on warfarin after starting spirulina. The mechanism is likely vitamin K antagonism. Patients on warfarin should avoid spirulina or monitor INR closely.
Spirulina may also have immunostimulatory effects (e.g., increased natural killer cell activity, as shown by Nielsen et al., 2010, PMID 20372921). In theory, this could interfere with immunosuppressive drugs (e.g., cyclosporine, tacrolimus). We advise caution in transplant recipients or those with autoimmune diseases.
Contraindications include phenylketonuria (spirulina contains phenylalanine) and hyperuricemia (spirulina is high in nucleic acids, which may raise uric acid). Individuals with seafood or iodine allergies should also be cautious, as spirulina may contain trace iodine.
Sourcing and Quality Markers
We recommend spirulina from producers that adhere to GMP and provide batch-specific COAs. Key markers: phycocyanin ≥15%, microcystins <1 ppb, lead <0.5 ppm, arsenic <1 ppm, mercury <0.1 ppm, cadmium <0.5 ppm. Look for organic certification and cultivation in controlled environments (e.g., Hawaii, California, or France). Avoid spirulina from open lakes where contamination risk is higher.
Frequently Asked Questions
Can I take spirulina while pregnant?
We advise against routine use due to limited safety data and contamination risks. If you choose to take it, limit to 1 g/day from a tested source and consult your midwife or doctor.
Is spirulina safe while breastfeeding?
There are no studies on spirulina in breast milk. We recommend avoiding it unless under medical supervision, due to potential transfer of contaminants.
Can children take spirulina?
For children over 2 years, a low dose (0.5–1 g/day) may be considered with paediatric approval. For younger children, we do not recommend it.
What are the side effects of spirulina?
Common side effects include mild digestive upset, headache, or allergic reactions. Contaminated products may cause liver toxicity or heavy metal poisoning.
Does spirulina interact with medications?
Yes, especially warfarin (anticoagulant) and immunosuppressants. Consult a pharmacist or doctor before use.
How do I choose a safe spirulina product?
Look for third-party testing (COA), GMP certification, organic label, and low heavy metal levels. Avoid wild-harvested spirulina.
Where to try it. If you want to source what we have described in this article, a transparent UK Spirulina supplier is the option we point readers to. This site is published by Vitadefence Ltd; we disclose that here.